Annual CFO
-$5.80 M
+$1.30 M+18.34%
31 December 2023
Summary:
ZIVO Bioscience annual cash flow from operations is currently -$5.80 million, with the most recent change of +$1.30 million (+18.34%) on 31 December 2023. During the last 3 years, it has risen by +$1.00 million (+14.75%).ZIVO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.08 M
-$461.30 K-73.96%
30 September 2024
Summary:
ZIVO Bioscience quarterly cash flow from operations is currently -$1.08 million, with the most recent change of -$461.30 thousand (-73.96%) on 30 September 2024. Over the past year, it has dropped by -$369.30 thousand (-51.60%).ZIVO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$4.12 M
+$884.50 K+17.66%
30 September 2024
Summary:
ZIVO Bioscience TTM cash flow from operations is currently -$4.12 million, with the most recent change of +$884.50 thousand (+17.66%) on 30 September 2024. Over the past year, it has increased by +$1.68 million (+28.90%).ZIVO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -51.6% | +28.9% |
| 3 y3 years | +14.8% | +42.9% | +39.4% |
| 5 y5 years | -56.5% | -66.6% | -11.2% |
ZIVO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +18.3% | -74.0% | +62.1% | at high | +52.1% |
| 5 y | 5 years | -124.1% | +18.3% | -219.4% | +62.1% | -76.3% | +52.1% |
| alltime | all time | <-9999.0% | +18.3% | <-9999.0% | +62.1% | <-9999.0% | +52.1% |
ZIVO Bioscience Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.08 M(+74.0%) | -$4.12 M(-17.7%) |
| June 2024 | - | -$623.70 K(-63.3%) | -$5.01 M(-6.7%) |
| Mar 2024 | - | -$1.70 M(+137.4%) | -$5.37 M(-7.4%) |
| Dec 2023 | -$5.80 M(-18.3%) | -$715.70 K(-63.7%) | -$5.80 M(-11.2%) |
| Sept 2023 | - | -$1.97 M(+99.8%) | -$6.53 M(+8.0%) |
| June 2023 | - | -$985.70 K(-53.7%) | -$6.05 M(-5.0%) |
| Mar 2023 | - | -$2.13 M(+47.1%) | -$6.37 M(-10.3%) |
| Dec 2022 | -$7.10 M(+4.4%) | -$1.45 M(-2.8%) | -$7.10 M(-6.0%) |
| Sept 2022 | - | -$1.49 M(+14.0%) | -$7.56 M(-4.0%) |
| June 2022 | - | -$1.31 M(-54.4%) | -$7.87 M(-8.6%) |
| Mar 2022 | - | -$2.86 M(+50.5%) | -$8.61 M(+26.6%) |
| Dec 2021 | -$6.80 M(+162.8%) | -$1.90 M(+5.6%) | -$6.80 M(+17.2%) |
| Sept 2021 | - | -$1.80 M(-12.1%) | -$5.80 M(+27.1%) |
| June 2021 | - | -$2.05 M(+94.7%) | -$4.57 M(+59.8%) |
| Mar 2021 | - | -$1.05 M(+16.7%) | -$2.86 M(+10.4%) |
| Dec 2020 | -$2.59 M(-30.2%) | -$901.50 K(+59.8%) | -$2.59 M(+10.7%) |
| Sept 2020 | - | -$564.10 K(+66.1%) | -$2.34 M(-24.6%) |
| June 2020 | - | -$339.70 K(-56.6%) | -$3.10 M(-20.8%) |
| Mar 2020 | - | -$783.10 K(+20.2%) | -$3.91 M(+5.6%) |
| Dec 2019 | -$3.71 M(-26.0%) | -$651.30 K(-50.9%) | -$3.71 M(-11.3%) |
| Sept 2019 | - | -$1.33 M(+15.0%) | -$4.18 M(+2.4%) |
| June 2019 | - | -$1.15 M(+100.2%) | -$4.08 M(-13.3%) |
| Mar 2019 | - | -$576.20 K(-48.8%) | -$4.71 M(-5.9%) |
| Dec 2018 | -$5.01 M(+18.0%) | -$1.12 M(-8.5%) | -$5.01 M(-4.5%) |
| Sept 2018 | - | -$1.23 M(-30.9%) | -$5.24 M(+0.0%) |
| June 2018 | - | -$1.78 M(+103.5%) | -$5.24 M(+14.3%) |
| Mar 2018 | - | -$874.00 K(-35.8%) | -$4.59 M(+8.1%) |
| Dec 2017 | -$4.24 M(+66.8%) | -$1.36 M(+11.0%) | -$4.24 M(+14.7%) |
| Sept 2017 | - | -$1.23 M(+9.3%) | -$3.70 M(+27.0%) |
| June 2017 | - | -$1.12 M(+112.1%) | -$2.91 M(+25.8%) |
| Mar 2017 | - | -$529.50 K(-35.4%) | -$2.31 M(-9.0%) |
| Dec 2016 | -$2.54 M(+10.7%) | -$819.80 K(+86.1%) | -$2.54 M(+15.1%) |
| Sept 2016 | - | -$440.50 K(-16.1%) | -$2.21 M(-5.0%) |
| June 2016 | - | -$525.00 K(-30.8%) | -$2.33 M(-12.3%) |
| Mar 2016 | - | -$758.20 K(+55.8%) | -$2.65 M(+15.5%) |
| Dec 2015 | -$2.30 M(-16.0%) | -$486.50 K(-12.5%) | -$2.30 M(+8.9%) |
| Sept 2015 | - | -$556.10 K(-34.8%) | -$2.11 M(-23.8%) |
| June 2015 | - | -$852.50 K(+112.2%) | -$2.77 M(+12.6%) |
| Mar 2015 | - | -$401.80 K(+34.9%) | -$2.46 M(-10.2%) |
| Dec 2014 | -$2.74 M(-8.4%) | -$297.90 K(-75.5%) | -$2.74 M(-15.4%) |
| Sept 2014 | - | -$1.22 M(+123.9%) | -$3.23 M(+15.4%) |
| June 2014 | - | -$542.60 K(-20.3%) | -$2.80 M(-9.9%) |
| Mar 2014 | - | -$680.50 K(-14.4%) | -$3.11 M(+4.2%) |
| Dec 2013 | -$2.99 M(+68.4%) | -$794.60 K(+1.4%) | -$2.99 M(+17.2%) |
| Sept 2013 | - | -$783.50 K(-8.0%) | -$2.55 M(+14.1%) |
| June 2013 | - | -$851.90 K(+53.1%) | -$2.23 M(+24.4%) |
| Mar 2013 | - | -$556.30 K(+56.0%) | -$1.80 M(+1.2%) |
| Dec 2012 | -$1.77 M | -$356.70 K(-23.9%) | -$1.77 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$468.60 K(+13.2%) | -$1.94 M(+12.4%) |
| June 2012 | - | -$413.80 K(-22.5%) | -$1.73 M(+14.5%) |
| Mar 2012 | - | -$534.20 K(+2.0%) | -$1.51 M(+16.5%) |
| Dec 2011 | -$1.29 M(-10.1%) | -$523.70 K(+105.9%) | -$1.29 M(+41.2%) |
| Sept 2011 | - | -$254.40 K(+30.3%) | -$916.20 K(-5.5%) |
| June 2011 | - | -$195.30 K(-39.1%) | -$969.50 K(+14.7%) |
| Mar 2011 | - | -$320.70 K(+120.0%) | -$845.20 K(-41.3%) |
| Dec 2010 | -$1.44 M(+25.2%) | -$145.80 K(-52.6%) | -$1.44 M(-11.6%) |
| Sept 2010 | - | -$307.70 K(+333.4%) | -$1.63 M(-14.6%) |
| June 2010 | - | -$71.00 K(-92.2%) | -$1.91 M(-2.6%) |
| Mar 2010 | - | -$915.20 K(+172.8%) | -$1.96 M(+70.3%) |
| Dec 2009 | -$1.15 M(+22.9%) | -$335.50 K(-42.7%) | -$1.15 M(+30.5%) |
| Sept 2009 | - | -$585.90 K(+382.2%) | -$881.10 K(+124.7%) |
| June 2009 | - | -$121.50 K(+13.3%) | -$392.20 K(-40.6%) |
| Mar 2009 | - | -$107.20 K(+61.2%) | -$660.20 K(-29.5%) |
| Dec 2008 | -$935.80 K(-33.5%) | -$66.50 K(-31.4%) | -$935.80 K(-13.4%) |
| Sept 2008 | - | -$97.00 K(-75.1%) | -$1.08 M(-20.1%) |
| June 2008 | - | -$389.50 K(+1.8%) | -$1.35 M(+3.3%) |
| Mar 2008 | - | -$382.80 K(+81.3%) | -$1.31 M(-6.9%) |
| Dec 2007 | -$1.41 M(-32.7%) | -$211.20 K(-42.8%) | -$1.41 M(-11.0%) |
| Sept 2007 | - | -$369.30 K(+6.7%) | -$1.58 M(-19.9%) |
| June 2007 | - | -$346.00 K(-27.9%) | -$1.97 M(-4.2%) |
| Mar 2007 | - | -$480.20 K(+24.7%) | -$2.06 M(-1.4%) |
| Dec 2006 | -$2.09 M(+26.7%) | -$385.00 K(-49.5%) | -$2.09 M(-4.2%) |
| Sept 2006 | - | -$762.30 K(+76.3%) | -$2.18 M(+23.7%) |
| June 2006 | - | -$432.30 K(-15.2%) | -$1.76 M(-0.7%) |
| Mar 2006 | - | -$509.70 K(+6.7%) | -$1.78 M(+7.7%) |
| Dec 2005 | -$1.65 M(+28.8%) | -$477.50 K(+38.9%) | -$1.65 M(+11.3%) |
| Sept 2005 | - | -$343.80 K(-22.7%) | -$1.48 M(-4.8%) |
| June 2005 | - | -$444.90 K(+16.1%) | -$1.56 M(+7.5%) |
| Mar 2005 | - | -$383.30 K(+23.6%) | -$1.45 M(+13.0%) |
| Dec 2004 | -$1.28 M(+7260.3%) | -$310.00 K(-25.9%) | -$1.28 M(+29.6%) |
| Sept 2004 | - | -$418.20 K(+24.4%) | -$988.10 K(+73.4%) |
| June 2004 | - | -$336.30 K(+55.6%) | -$569.90 K(+144.0%) |
| Mar 2004 | - | -$216.20 K(+1142.5%) | -$233.60 K(+1242.5%) |
| Dec 2003 | -$17.40 K(<-9900.0%) | -$17.40 K(<-9900.0%) | -$17.40 K(<-9900.0%) |
| Sept 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00 | $0.00 |
| Dec 2000 | $0.00 | - | - |
FAQ
- What is ZIVO Bioscience annual cash flow from operations?
- What is the all time high annual CFO for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly CFO year-on-year change?
- What is ZIVO Bioscience TTM cash flow from operations?
- What is the all time high TTM CFO for ZIVO Bioscience?
- What is ZIVO Bioscience TTM CFO year-on-year change?
What is ZIVO Bioscience annual cash flow from operations?
The current annual CFO of ZIVO is -$5.80 M
What is the all time high annual CFO for ZIVO Bioscience?
ZIVO Bioscience all-time high annual cash flow from operations is $0.00
What is ZIVO Bioscience quarterly cash flow from operations?
The current quarterly CFO of ZIVO is -$1.08 M
What is the all time high quarterly CFO for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly cash flow from operations is $0.00
What is ZIVO Bioscience quarterly CFO year-on-year change?
Over the past year, ZIVO quarterly cash flow from operations has changed by -$369.30 K (-51.60%)
What is ZIVO Bioscience TTM cash flow from operations?
The current TTM CFO of ZIVO is -$4.12 M
What is the all time high TTM CFO for ZIVO Bioscience?
ZIVO Bioscience all-time high TTM cash flow from operations is $0.00
What is ZIVO Bioscience TTM CFO year-on-year change?
Over the past year, ZIVO TTM cash flow from operations has changed by +$1.68 M (+28.90%)